PhaseBio Pharmaceuticals: Ownership & structure
AstraZeneca holds 10.44% of PhaseBio Pharmaceuticals.
Data updated Nov 21, 2026 · Back to the company report
Owners & entities
AstraZeneca holds 10.44% of PhaseBio Pharmaceuticals.
Holders
owner of (stated on the holder) · wikidata.org ↗
10.44%
Holders and shares as each register or filing states them.
Connections
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors

NEAVia a fund
672 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Shared investors
